Austar Lifesciences Limited

Equities

6118

KYG0632L1023

Medical Equipment, Supplies & Distribution

Market Closed - Hong Kong S.E. Other stock markets 09:08:03 23/05/2024 BST			5-day change	1st Jan Change
0.84 ^HKD	+2.44%		+2.44%	-46.15%

03-26	Austar Lifesciences Limited Reports Earnings Results for the Full Year Ended December 31, 2023	CI
01-22	Austar Lifesciences to Swing to Loss; Shares Drop	MT

Austar Lifesciences Limited Provides Consolidated Earnings Guidance for the Year Ending 31 December 2018

December 24, 2018 at 04:31 am

Austar Lifesciences Limited provided consolidated earnings guidance for the year ending 31 December 2018. The group is expected to record a substantial decrease in loss for the year ending 31 December 2018 as compared to the loss for the year ended 31 December 2017 of approximately RMB 54.2 million.

Latest news about Austar Lifesciences Limited

Austar Lifesciences Limited Reports Earnings Results for the Full Year Ended December 31, 2023	03-26	CI
Austar Lifesciences to Swing to Loss; Shares Drop	01-22	MT
Austar Lifesciences Limited Provides Consolidated Earnings Guidance for the Year Ended 31 December 2023	01-19	CI
Austar Lifesciences Hires New Auditor	11-17	MT
Austar Lifesciences Swings to Loss in H1	30/08/23	MT
Austar Lifesciences Limited Reports Earnings Results for the Half Year Ended June 30, 2023	29/08/23	CI
ValGenesis, Inc. and AUSTAR Group Partner to Deploy Digital, Risk-Based Solutions for Life Sciences Companies in China	15/08/23	CI
Austar Lifesciences Expects Higher Loss in H1	04/08/23	MT
Austar Lifesciences Limited Updates Consolidated Group Earnings Guidance for the Six Months Ending June 30, 2023	03/08/23	CI
Austar Lifesciences Warns of H1 Loss	30/06/23	MT
Austar Lifesciences Limited Provides Group Earnings Guidance for the Six Months Ending 30 June 2023	30/06/23	CI
Austar Lifesciences Limited Reports Earnings Results for the Full Year Ended December 31, 2022	28/03/23	CI
Austar Lifesciences Expects 2022 Profit to Fall to 50 Million Yuan	06/02/23	MT
Austar Lifesciences Limited Provides Consolidated Earnings Guidance for the Year Ended 31 December 2022	03/02/23	CI
Austar Lifesciences Limited Announces Executive Changes	27/09/22	CI
Austar Lifesciences Limited(SEHK:6118) dropped from S&P Global BMI Index	19/09/22	CI
Austar Lifesciences Limited Reports Earnings Results for the Half Year Ended June 30, 2022	29/08/22	CI
Austar Lifesciences Forecasts H1 Profit Fall to $6.4 Million	08/08/22	MT
Austar Lifesciences Limited acquired an unknown minority interest in Noozle Fluid Technology Co., Ltd..	07/08/22	CI
Austar Lifesciences Limited Provides Earnings Guidance for the Six Months Ended 30 June 2022	05/08/22	CI
Austar Lifesciences Limited Reports Earnings Results for the Full Year Ended December 31, 2021	25/03/22	CI
Austar Lifesciences Completes Buy of Nanjing Bojian's Technology, Ancillary Business; Shares Rise 3%	02/03/22	MT
Austar Lifesciences Limited acquired the Technology and ancillary business of Nanjing Bojian Technology Co., Ltd from Nanjing Bojian Technology Co., Ltd.	28/02/22	CI
Hong Kong Stocks Extend Retreat; Austar Lifesciences Soars 25%	25/01/22	MT
Austar Lifesciences Forecasts Eightfold Increase in FY21 Profit; Shares Rally 24%	25/01/22	MT

Chart Austar Lifesciences Limited

Duration

Period

More charts

Company Profile

Austar Lifesciences Limited is principally engaged in the provision of integrated engineering solutions to pharmaceutical manufactures and research institutes and the manufacture and distribution of pharmaceutical equipment and consumables in China. The Company operates its business through six segments: liquid and bioprocess system segment, clean room and automation control and monitoring system segment, powder and solid system segment, good manufacturing practice (GMP) compliance service segment, life science consumables segment and distribution and agency of pharmaceutical equipment segment.

Sector

Medical Equipment, Supplies & Distribution

Calendar

25/08/2024 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Other Medical Equipment, Supplies & Distribution

	1st Jan change	Capi.
AUSTAR LIFESCIENCES LIMITED	-46.15%	53.84M
ABBOTT LABORATORIES	-5.00%	182B
MEDTRONIC PLC	+0.29%	114B
BECTON, DICKINSON AND COMPANY	-5.61%	67.76B
DEXCOM, INC.	+3.70%	51.91B
CENCORA, INC.	+7.08%	43.23B
HOYA CORPORATION	+6.07%	41.07B
METTLER-TOLEDO INTERNATIONAL, INC.	+23.33%	32.07B
TERUMO CORPORATION	+15.86%	25B
ZIMMER BIOMET HOLDINGS, INC.	-2.89%	24.55B

Other Medical Equipment, Supplies & Distribution